These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 27194200

  • 21. Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids.
    Peacock A, Bruno R, Cama E, Kihas I, Larance B, Lintzeris N, Hordern A, White N, Ali R, Degenhardt L.
    Drug Alcohol Rev; 2015 Nov; 34(6):611-22. PubMed ID: 26084592
    [Abstract] [Full Text] [Related]

  • 22. Use of an algorithm applied to urine drug screening to assess adherence to an oxycontin regimen.
    Couto JE, Webster L, Romney MC, Leider HL, Linden A.
    J Opioid Manag; 2009 Nov; 5(6):359-64. PubMed ID: 20073409
    [Abstract] [Full Text] [Related]

  • 23. The characteristics of a cohort who tamper with prescribed and diverted opioid medications.
    Larance B, Lintzeris N, Bruno R, Peacock A, Cama E, Ali R, Kihas I, Hordern A, White N, Degenhardt L.
    J Subst Abuse Treat; 2015 Nov; 58():51-61. PubMed ID: 26286818
    [Abstract] [Full Text] [Related]

  • 24. Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment.
    Dennis BB, Roshanov PS, Bawor M, Paul J, Varenbut M, Daiter J, Plater C, Pare G, Marsh DC, Worster A, Desai D, Thabane L, Samaan Z.
    Pain Physician; 2016 Jan; 19(1):E181-95. PubMed ID: 26752486
    [Abstract] [Full Text] [Related]

  • 25. Gender-specific predictors of methadone treatment outcomes among African Americans at an urban clinic.
    Lister JJ, Brown S, Greenwald MK, Ledgerwood DM.
    Subst Abus; 2019 Jan; 40(2):185-193. PubMed ID: 30888262
    [Abstract] [Full Text] [Related]

  • 26. Comparing treatment-seeking codeine users and strong opioid users: Findings from a novel case series.
    Nielsen S, Murnion B, Dunlop A, Degenhardt L, Demirkol A, Muhleisen P, Lintzeris N.
    Drug Alcohol Rev; 2015 May; 34(3):304-11. PubMed ID: 25545541
    [Abstract] [Full Text] [Related]

  • 27. The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study.
    Degenhardt L, Bruno R, Ali R, Lintzeris N, Farrell M, Larance B.
    Drug Alcohol Depend; 2015 Jun 01; 151():56-67. PubMed ID: 25910850
    [Abstract] [Full Text] [Related]

  • 28. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
    Levine AR, Lundahl LH, Ledgerwood DM, Lisieski M, Rhodes GL, Greenwald MK.
    J Subst Abuse Treat; 2015 Jul 01; 54():37-43. PubMed ID: 25795601
    [Abstract] [Full Text] [Related]

  • 29. Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series.
    Nielsen S, Bruno R, Degenhardt L, Demirkol A, Lintzeris N.
    Drug Alcohol Rev; 2017 May 01; 36(3):311-316. PubMed ID: 27273511
    [Abstract] [Full Text] [Related]

  • 30. A naturalistic comparison of the effectiveness of methadone and two sublingual formulations of buprenorphine on maintenance treatment outcomes: findings from a retrospective multisite study.
    Proctor SL, Copeland AL, Kopak AM, Herschman PL, Polukhina N.
    Exp Clin Psychopharmacol; 2014 Oct 01; 22(5):424-33. PubMed ID: 25069011
    [Abstract] [Full Text] [Related]

  • 31. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
    White WL, Campbell MD, Spencer RD, Hoffman HA, Crissman B, DuPont RL.
    J Psychoactive Drugs; 2014 Oct 01; 46(2):114-22. PubMed ID: 25052787
    [Abstract] [Full Text] [Related]

  • 32. Bioequivalence of oxycodone hydrochoride extended release tablets to marketed reference products OxyContin® in Canada and US.
    Gosai P, Ducharme MP, Godfrey AR, Freeman JC, Monif T, Kumar KS, Kumar S, Mudnaik R, Katikaneni P.
    Int J Clin Pharmacol Ther; 2013 Nov 01; 51(11):895-907. PubMed ID: 23673291
    [Abstract] [Full Text] [Related]

  • 33. Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent properties.
    Janoff SL, Perrin NA, Coplan PM, Chilcoat HD, Campbell CI, Green CA.
    BMC Pharmacol Toxicol; 2016 May 14; 17(1):21. PubMed ID: 27177423
    [Abstract] [Full Text] [Related]

  • 34. Don't tamper with oxycodone.
    Fletcher J, Tsuyuki R.
    CMAJ; 2013 Feb 05; 185(2):107. PubMed ID: 23296585
    [No Abstract] [Full Text] [Related]

  • 35. Furosemide as a potential unintended urine drug screen confounder during methadone maintenance treatment.
    Bauer RL, Geminn WL, Carter JA.
    J Opioid Manag; 2015 Feb 05; 11(5):449-52. PubMed ID: 26535973
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of an implementation of methadone maintenance treatment in China.
    Marienfeld C, Liu P, Wang X, Schottenfeld R, Zhou W, Chawarski MC.
    Drug Alcohol Depend; 2015 Dec 01; 157():60-7. PubMed ID: 26601934
    [Abstract] [Full Text] [Related]

  • 37. Predictors of patient retention in methadone maintenance treatment.
    Proctor SL, Copeland AL, Kopak AM, Hoffmann NG, Herschman PL, Polukhina N.
    Psychol Addict Behav; 2015 Dec 01; 29(4):906-17. PubMed ID: 26098127
    [Abstract] [Full Text] [Related]

  • 38. Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients.
    Huhn AS, Sweeney MM, Brooner RK, Kidorf MS, Tompkins DA, Ayaz H, Dunn KE.
    Neuropsychopharmacology; 2019 Mar 01; 44(4):826-833. PubMed ID: 30375498
    [Abstract] [Full Text] [Related]

  • 39. Illicit Heroin and Methamphetamine Use among Methadone Maintenance Treatment Patients in Dehong Prefecture of Yunnan Province, China.
    Wang R, Ding Y, Bai H, Duan S, Ye R, Yang Y, Wang J, Tang R, Gao M, He N.
    PLoS One; 2015 Mar 01; 10(7):e0133431. PubMed ID: 26196394
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.